C‑terminal HSP90 inhibitor NCT‑58 impairs the cancer stem‑like phenotype and enhances chemotherapy efficacy in TNBC
C端HSP90抑制剂NCT-58可削弱三阴性乳腺癌(TNBC)的癌干细胞样表型并增强化疗疗效。
期刊:Oncology Reports
影响因子:3.9
doi:10.3892/or.2025.9018
Jung, Eunsun; Kim, Yoon-Jae; Lee, Kyoungmin; Jang, Seojin; Park, Soeun; Oh, Eunhye; Park, Minsu; Kim, Seongjae; Ko, Dongmi; Kang, Yong Koo; Nam, Kee Dal; Farrand, Lee; Nguyen, Cong-Truong; La, Minh Thanh; Ann, Jihyae; Lee, Jeewoo; Kim, Ji Young; Seo, Jae Hong
肿瘤
肿瘤免疫
细胞生物学
乳腺癌
干细胞
发育与干细胞
HSP90